New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders

被引:29
作者
Gingrich, JA [1 ]
Ansorge, MS [1 ]
Merker, R [1 ]
Weisstaub, N [1 ]
Zhou, MM [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Psychiat, Div Dev Psychobiol, New York, NY 10032 USA
关键词
D O I
10.1017/S1092852900018848
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Serotonin (5-HT) modulates numerous processes in the central nervous system that are relevant to neuropsychiatric function and dysfunction, It exerts significant effects on anxiety, mood, impulsivity, sleep, ingestive behaviors, reward system, and psychosis. Serotonergic dysfunction, has been implicated in several neuropsychiatric conditions but efforts to more clearly understand the mechanisms of this influence have been hampered by the complexity of this system at the receptor level. There are at least 14 distinct receptors that mediate the effects of 5-HT as well as several enzymes that control its synthesis and metabolism. Pharmacologic agents that target specific receptors hate provided clues regarding the function of these receptors in the adult brain. 5-HT is also an important modulator of neural development and several groups have employed a genetic strategy to ablate specific components of the 5,HT system m order to understand the role of different serotonergic in development of brain system relevant to behavior. Several inactivation mutations of specific 5-HT receptors have been generated producing interesting behavioral phenotypes related to anxiety, depression, drug abut psychosis, and cognition. In many cases, knockout mice have been used to confirm what has already been suspected based on pharmacologic studies. In other instances, mutations have demonstrated new functions of serotonergic genes in development and behavior.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 63 条
[31]   Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice [J].
Kelley, SP ;
Bratt, AM ;
Hodge, CW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 461 (01) :19-25
[32]   Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety [J].
Kent, JM ;
Coplan, JD ;
Gorman, JM .
BIOLOGICAL PSYCHIATRY, 1998, 44 (09) :812-824
[33]   Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region [J].
Lesch, KP ;
Bengel, D ;
Heils, A ;
Sabol, SZ ;
Greenberg, BD ;
Petri, S ;
Benjamin, J ;
Muller, CR ;
Hamer, DH ;
Murphy, DL .
SCIENCE, 1996, 274 (5292) :1527-1531
[34]  
LIRA A, IN PRESS BIOL PSYCHI
[35]   Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice [J].
Liu, XQ ;
Gershenfeld, HK .
BIOLOGICAL PSYCHIATRY, 2001, 49 (07) :575-581
[36]   Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice [J].
Lucki, I ;
Dalvi, A ;
Mayorga, AJ .
PSYCHOPHARMACOLOGY, 2001, 155 (03) :315-322
[37]   5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex [J].
Malagié, I ;
Trillat, AC ;
Bourin, M ;
Jacquot, C ;
Hen, R ;
Gardier, AM .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (03) :865-871
[38]   A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical finding in major depression and suicide [J].
Mann, JJ ;
Huang, JY ;
Underwood, MD ;
Kassir, SA ;
Oppenheim, S ;
Kelly, TM ;
Dwork, AJ ;
Arango, V .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (08) :729-738
[39]   The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system [J].
Mann, JJ ;
Brent, DA ;
Arango, V .
NEUROPSYCHOPHARMACOLOGY, 2001, 24 (05) :467-477
[40]  
Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101